Baclofen Impurity 24 | CAS 54795-01-6 - Request Quote
Baclofen Impurity 24
| SZ CAT No: | SZ-B050033 |
| CAS No | 54795-01-6 |
| Mol.F. | C13H13ClO |
| Mol.Wt. | 220.7 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Baclofen Impurity 24 is chemically 4'-Chloro-5-methyl-1,6-dihydro-[1,1'-biphenyl]-3(2H)-one. Baclofen Impurity 24 is supplied with detailed characterization data compliant with regulatory guideline. Baclofen Impurity 24 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Baclofen.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 54795-01-6
Purchase 54795-01-6
Order 54795-01-6
Enquire 54795-01-6
price of 54795-01-6
54795-01-6 Supplier
54795-01-6 Manufacturer
54795-01-6 Exporter
buy high quality Baclofen Impurity 24
Purchase Baclofen Impurity 24
Baclofen Impurity 24 suppliers
Baclofen Impurity 24 manufacturers
Baclofen Impurity 24 price
Order Baclofen Impurity 24
Enquire Baclofen Impurity 24
Baclofen Impurity 24 cost
Baclofen Impurity 24 Supplier
Baclofen Impurity 24 Distributor
Baclofen Impurity 24 for Method Validation
Baclofen Reference Standard
Baclofen Impurity 24 for ANDA Filing
Baclofen Impurity 24 for Forced Degradation Studies
Baclofen Impurity 24 Identification Standards
Baclofen Impurity 24 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


